CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 44 enrolled
Drug / intervention
Erchonia EVRLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03941912
NCT03941912N/ACompleted
CompareCT.gov

An Evaluation of the Erchonia EVRL on Neck and Shoulder Pain of Musculoskeletal Origin

Erchonia Corporation·interventional·Posted May 8, 2019·Updated Oct 14, 2021

In Brief

A clinical study evaluating Erchonia EVRL for Musculoskeletal Pain. Completed, enrolled 44 participants across 2 sites.

Detailed Summary

This study is to see if applying red and violet low level laser light to the neck and shoulders can help to reduce pain in the neck and shoulders.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMusculoskeletal Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 8, 2019
Enrollment StartApr 16, 2018
Primary CompletionMar 10, 2019
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 7.1 years ago

Interventions

Erchonia EVRLdevice

Single treatment with the Erchonia EVRL to the neck and shoulders. The treatment applies 635 nanometers (nm) red diode light and 405 nm violet diode light simultaneously.